Evaluation of the Roche-SD Biosensor rapid antigen test: Antigen is not reliable in detecting SARS-CoV-2 at the early stage of infection with respiratory symptoms

Heini Flinck, Dominik Kerimov, Bruno Luukinen, Tapio Seiskari, Janne Aittoniemi

Research output: Contribution to journalArticleScientificpeer-review

6 Citations (Scopus)

Abstract

We evaluated a rapid antigen test against SARS-CoV-2 virus (Roche-SD Biosensor; RSDB-RAT) in children and adults with respiratory symptoms compared to those with nonrespiratory symptoms or asymptomatic. Also the performance of RSDB-RAT with respect to the duration of respiratory symptoms was assessed. A viral cross-reactivity panel was included. RSDB-RAT was reliable in detecting SARS-CoV-2 in children and adults if the respiratory symptoms had endured 1 to 7 days. If the respiratory symptoms had lasted less than 1 day, the sensitivity was significantly lower. No cross-reactivity with other respiratory viruses was observed.

Original languageEnglish
Article number115628
JournalDIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
Volume102
Issue number4
Early online dateDec 2021
DOIs
Publication statusPublished - Apr 2022
Publication typeA1 Journal article-refereed

Funding

The study was supported by an institutional grant of Tampere Tuberculosis Foundation (Tampere, Finland). The funder had no role of study design, data collection and interpretation, or the decision to submit the work for publication.

Keywords

  • COVID-19
  • Rapid antigen test
  • SARS-CoV-2

Publication forum classification

  • Publication forum level 1

ASJC Scopus subject areas

  • Microbiology (medical)
  • Infectious Diseases

Fingerprint

Dive into the research topics of 'Evaluation of the Roche-SD Biosensor rapid antigen test: Antigen is not reliable in detecting SARS-CoV-2 at the early stage of infection with respiratory symptoms'. Together they form a unique fingerprint.

Cite this